Evidence map›Paper›PMID 30508769›Full record

Trial reportDrug and alcohol dependence2019

An evaluation of the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy for opioid use disorder and chronic pain.

Declan T Barry, Mark Beitel, Christopher J Cutter, David A Fiellin, Robert D Kerns, Brent A Moore, Lindsay Oberleitner, Lynn M Madden, Christopher Liong, Joel Ginn and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 5 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 5 syntheses or guidelines pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Developing a novel treatment for patients with chronic pain and Opioid User Disorder.Substance abuse treatment, prevention, and policy · 2022
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Declan T BarryYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; APT Foundation Pain Treatment Services, New Haven, CT, 06519, United States. Electronic address: declan.barry@yale.edu.
Mark BeitelYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; APT Foundation Pain Treatment Services, New Haven, CT, 06519, United States.
Christopher J CutterYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; APT Foundation Pain Treatment Services, New Haven, CT, 06519, United States.
David A FiellinYale School of Medicine, Department of Internal Medicine, New Haven, CT, 06519, United States.
Robert D KernsYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; VA Connecticut Healthcare System, West Haven, CT, 06516, United States.
Brent A MooreYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; VA Connecticut Healthcare System, West Haven, CT, 06516, United States.
Lindsay OberleitnerYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; APT Foundation Pain Treatment Services, New Haven, CT, 06519, United States.
Lynn M MaddenYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States; APT Foundation Pain Treatment Services, New Haven, CT, 06519, United States.
Christopher LiongAPT Foundation Pain Treatment Services, New Haven, CT, 06519, United States.
Joel GinnAPT Foundation Pain Treatment Services, New Haven, CT, 06519, United States.
Richard S SchottenfeldYale School of Medicine, Department of Psychiatry, New Haven, CT, 06511, United States.
Yale University · USAPT Foundation · US

Funding

Pain and Opioid Dependence (POD)R01DA024695 · NIDA · YALE UNIVERSITY · PI SCHOTTENFELD, RICHARD S · 2009 to 2012
$1.4M
IMPROVING EFFICACY OF DRUG ABUSE TREATMENTK24DA000445 · NIDA · YALE UNIVERSITY · PI SCHOTTENFELD, RICHARD S · 2000 to 2009
$1.3M
Chronic Pain and Opioid Dependence Assessment and TreatmentK23DA024050 · NIDA · YALE UNIVERSITY · PI BARRY, DECLAN T. · 2008 to 2012
$901k
Computer-Based Treatment for Drug DependenceK01DA022398 · NIDA · YALE UNIVERSITY · PI MOORE, BRENT A. · 2008 to 2011
$725k
NIDA NIH HHS K01 DA022398NIDA NIH HHS K23 DA024050NIDA NIH HHS K24 DA000445NIDA NIH HHS R01 DA024695
6 · The paper itself

Abstract

aimsThe primary study aim was to evaluate the feasibility and acceptability of cognitive-behavioral therapy (CBT) for opioid use disorder and chronic pain. The secondary aim was to examine its preliminary efficacy.

methodsIn a 12-week pilot randomized clinical trial, 40 methadone-maintained patients were assigned to receive weekly manualized CBT (n = 21) or Methadone Drug Counseling (MDC) to approximate usual drug counseling (n = 19).

resultsTwenty of 21 patients assigned to CBT and 18 of 19 assigned to MDC completed the pilot study. Mean (SD) sessions attended were 8.4 (2.9) for CBT (out of 12 possible) and 3.8 (1.1) for MDC (out of 4 possible); mean (SD) patient satisfaction ratings (scored on 1-7 Likert-type scales) were 6.6 (0.5) for CBT and 6.0 (0.4) for MDC (p < .001). The proportion of patients abstinent during the baseline and each successive 4-week interval was higher for patients assigned to CBT than for those assigned to MDC [Wald χ

conclusionsWe found support for the feasibility, acceptability, and preliminary efficacy of cognitive-behavioral therapy relative to standard drug counseling in promoting abstinence from nonmedical opioid use among patients with opioid use disorder and chronic pain. Overall, patients exhibited improved pain outcomes, but these improvements did not differ significantly by treatment condition.

Indexed as

Cognitive Behavioral TherapyPatient SatisfactionAdultAnalgesics, OpioidChronic PainCombined Modality TherapyFeasibility StudiesFemaleHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersPilot ProjectsTreatment OutcomeAnalgesics, OpioidMethadoneChronic painClinical trialCognitive therapyCounselingMethadoneOpioid-related disordersTreatment outcome

Identifiers

PMID30508769
PMCPMC6312460
OpenAlexW2900624226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.